Filing Details
- Accession Number:
- 0000904454-13-000764
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-02 16:48:16
- Reporting Period:
- 2013-07-01
- Filing Date:
- 2013-07-02
- Accepted Time:
- 2013-07-02 16:48:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1434868 | Esperion Therapeutics Inc. | ESPR | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1207786 | H Brian Dovey | C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-07-01 | 1,786,012 | $0.00 | 1,786,012 | No | 4 | C | Indirect | By Domain Partners VII, L.P. |
Common Stock | Acquisiton | 2013-07-01 | 280,923 | $14.00 | 2,066,935 | No | 4 | P | Indirect | By Domain Partners VII, L.P. |
Common Stock | Acquisiton | 2013-07-01 | 30,462 | $0.00 | 30,462 | No | 4 | C | Indirect | By DP VII Associates, L.P. |
Common Stock | Acquisiton | 2013-07-01 | 4,791 | $14.00 | 35,253 | No | 4 | P | Indirect | By DP VII Associates, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | By Domain Partners VII, L.P. |
No | 4 | P | Indirect | By Domain Partners VII, L.P. |
No | 4 | C | Indirect | By DP VII Associates, L.P. |
No | 4 | P | Indirect | By DP VII Associates, L.P. |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Preferred Stock | Disposition | 2013-07-01 | 1,786,012 | $0.00 | 1,786,012 | $0.00 |
Series A Preferred Stock | Warrant to Purchase Series A Preferred Stock | Disposition | 2013-07-01 | 489,320 | $0.00 | 489,320 | $1.00 |
Common Stock | Warrant to Purchase Common Stock | Acquisiton | 2013-07-01 | 70,042 | $0.00 | 70,042 | $6.99 |
Common Stock | Series A Preferred Stock | Disposition | 2013-07-01 | 30,462 | $0.00 | 30,462 | $0.00 |
Series A Preferred Stock | Warrant to Purchase Series A Preferred Stock | Disposition | 2013-07-01 | 8,346 | $0.00 | 8,346 | $1.00 |
Common Stock | Warrant to Purchase Common Stock | Acquisiton | 2013-07-01 | 1,193 | $0.00 | 1,193 | $6.99 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | J | Indirect | ||
70,042 | 2018-02-12 | No | 4 | J | Indirect | |
0 | No | 4 | C | Indirect | ||
0 | No | 4 | J | Indirect | ||
1,193 | 2018-02-12 | No | 4 | J | Indirect |
Footnotes
- All outstanding shares of Series A Preferred Stock were automatically converted into Common Stock upon the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration.
- Upon the closing of the IPO the Warrants to purchase Series A Preferred Stock automatically converted on a 6.986-for-1 basis into Warrants to purchase Common Stock, and the exercise price automatically adjusted to $6.99 per share, pursuant to the terms of such Warrants. This transaction is reported on Form 4 solely for the purpose of reflecting such changes.
- The Warrant is immediately exercisable.
- The Reporting Person also indirectly beneficially owns 21,471 shares of Common Stock held by Domain Associates, LLC. The Reporting Person is a Managing Member of (i) One Palmer Square Associates VII, LLC, which is the sole general partner of Domain Partners VII, L.P. and DP VII Associates, L.P. and (ii) Domain Associates, LLC. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.